UPDATE: Deutsche Bank Initiates Coverage on Allscripts Healthcare Solutions with Buy Rating, $19 PT as Stock Accelerates Out of the Turn

In a report published Thursday, Deutsche Bank analyst George Hill initiated coverage on

with a Buy rating and $19.00 price target. In the report, Deutsche Bank noted, “We are initiating coverage on Allscripts with a Buy rating, as we believe the company is in the midst of a turnaround led by the new management team and a focus on Population Health. The company's new Population Health tools will allow Allscripts to gain share of wallet in its current installed base and gain a foothold in potential new footprints. The company's PHM tools layer on top of the solutions of other vendors, potentially serving as a Trojan horse for the company's other solutions.” Allscripts Healthcare Solutions closed on Wednesday at $14.26.